Bernardine Pinto1, Kevin Stein2, Shira Dunsiger3. 1. University of South Carolina, Columbia, SC, USA. 2. American Cancer Society, Atlanta, USA. 3. Miriam Hospital and Alpert Medical School of Brown University, Providence, USA.
Abstract
OBJECTIVE:Physical activity (PA) adoption can improve quality of life (QOL) and related outcomes among breast cancer survivors. To disseminate a telephone-based PA intervention to cancer survivors, we partnered with the American Cancer Society's Reach To Recovery program (RTR) whose volunteers (breast cancer survivors) provide information and emotional support to breast cancer survivors. METHOD: This randomized controlled trial compared the effects of PA telephone counseling delivered by RTR volunteers (PA Plus RTR) versus a contact control condition (RTR Control) in six New England states. RTR volunteers (n = 18; mean age = 54.9 years, mean years since breast cancer diagnosis = 7.0) delivered a 12-week PA program to help participants adopt 30 min of moderate-intensity activity ≥5 days/week. Breast cancer survivors (n = 76; mean age = 55.62 years, mean years since diagnosis = 1.11, Stage 0 = 6.58%, Stage 1 = 38.16%, Stage 2 = 44.74%, Stage 3 = 10.53%) were randomized to a study group. RESULTS: Using a series of generalized linear models, we assessed intervention effects on physical health, physical functioning, mental health, fatigue, and QOL at 12 and 24 weeks, and examined whether these effects were moderated by age, marital status, chemotherapy use, and baseline values of the outcomes. There were no significant intervention effects on the outcomes but there were significant moderator effects of age, chemotherapy use, and baseline physical functioning, physical health, and breast cancer-specific symptoms (all p's < .05). CONCLUSIONS: Specific demographic and treatment variables and baseline psychosocial health moderate the impact of PA interventions on QOL.
RCT Entities:
OBJECTIVE: Physical activity (PA) adoption can improve quality of life (QOL) and related outcomes among breast cancer survivors. To disseminate a telephone-based PA intervention to cancer survivors, we partnered with the American Cancer Society's Reach To Recovery program (RTR) whose volunteers (breast cancer survivors) provide information and emotional support to breast cancer survivors. METHOD: This randomized controlled trial compared the effects of PA telephone counseling delivered by RTR volunteers (PA Plus RTR) versus a contact control condition (RTR Control) in six New England states. RTR volunteers (n = 18; mean age = 54.9 years, mean years since breast cancer diagnosis = 7.0) delivered a 12-week PA program to help participants adopt 30 min of moderate-intensity activity ≥5 days/week. Breast cancer survivors (n = 76; mean age = 55.62 years, mean years since diagnosis = 1.11, Stage 0 = 6.58%, Stage 1 = 38.16%, Stage 2 = 44.74%, Stage 3 = 10.53%) were randomized to a study group. RESULTS: Using a series of generalized linear models, we assessed intervention effects on physical health, physical functioning, mental health, fatigue, and QOL at 12 and 24 weeks, and examined whether these effects were moderated by age, marital status, chemotherapy use, and baseline values of the outcomes. There were no significant intervention effects on the outcomes but there were significant moderator effects of age, chemotherapy use, and baseline physical functioning, physical health, and breast cancer-specific symptoms (all p's < .05). CONCLUSIONS: Specific demographic and treatment variables and baseline psychosocial health moderate the impact of PA interventions on QOL.
Authors: Justin C Brown; Tania B Huedo-Medina; Linda S Pescatello; Shannon M Pescatello; Rebecca A Ferrer; Blair T Johnson Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-11-04 Impact factor: 4.254
Authors: J F Sallis; W L Haskell; P D Wood; S P Fortmann; T Rogers; S N Blair; R S Paffenbarger Journal: Am J Epidemiol Date: 1985-01 Impact factor: 4.897
Authors: Matthew P Buman; Peter R Giacobbi; Joseph M Dzierzewski; Adrienne Aiken Morgan; Christina S McCrae; Beverly L Roberts; Michael Marsiske Journal: J Phys Act Health Date: 2011-09
Authors: Bernardine M Pinto; Georita M Frierson; Carolyn Rabin; Joseph J Trunzo; Bess H Marcus Journal: J Clin Oncol Date: 2005-05-20 Impact factor: 44.544
Authors: M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Kerry S Courneya; Christopher M Sellar; Clare Stevinson; Margaret L McNeely; Christine M Friedenreich; Carolyn J Peddle; Sanraj Basi; Neil Chua; Keith Tankel; Alex Mazurek; Tony Reiman Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10 Impact factor: 4.254
Authors: Karen Basen-Engquist; Catherine M Alfano; Melissa Maitin-Shepard; Cynthia A Thomson; Kathryn H Schmitz; Bernardine M Pinto; Kevin Stein; David S Zucker; Karen L Syrjala; Elizabeth Fallon; Colleen Doyle; Wendy Demark-Wahnefried Journal: Obesity (Silver Spring) Date: 2017-11 Impact factor: 5.002
Authors: Laura Q Rogers; Kerry S Courneya; Stephen J Carter; Philip M Anton; Steven Verhulst; Sandra K Vicari; Randall S Robbs; Edward McAuley Journal: Breast Cancer Res Treat Date: 2016-08-18 Impact factor: 4.872
Authors: Laura Q Rogers; Latoya Goncalves; Michelle Y Martin; Maria Pisu; Tamika L Smith; Danielle Hessong; Robert A Oster; Haiyan Qu; Richard Shewchuk; Fatima Iqbal; Mary E Sheffield; Alex Minter; Ana A Baumann Journal: J Cancer Surviv Date: 2019-06-27 Impact factor: 4.442
Authors: Kirsten N Adlard; David G Jenkins; Chloe E Salisbury; Kate A Bolam; Sjaan R Gomersall; Joanne F Aitken; Suzanne K Chambers; Jeff C Dunn; Kerry S Courneya; Tina L Skinner Journal: BMC Cancer Date: 2019-07-03 Impact factor: 4.430
Authors: Helen Mulholland; Jason C McIntyre; Alina Haines-Delmont; Richard Whittington; Terence Comerford; Rhiannon Corcoran Journal: BMJ Open Date: 2021-02-04 Impact factor: 2.692